Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma

Lignende værker

• Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies
  af: Nayar, Utthara, et al.
  Udgivet: (2013)
• Purine-Scaffold Hsp90 Inhibitors
  af: Taldone, Tony, et al.
  Udgivet: (2009)
• NF-κB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo
  af: Keller, Shannon A., et al.
  Udgivet: (2006)
• Chemical tools to investigate mechanisms associated with HSP90 and HSP70 in disease
  af: Shrestha, Liza, et al.
  Udgivet: (2016)
• A global view of Hsp90 functions
  af: Chiosis, Gabriela, et al.
  Udgivet: (2013)